Atlas Trials

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Clinical trial NCT03200704 · COMPLETED

Trial details

NCT number
NCT03200704
Sponsor
Novadaq Technologies ULC, now a part of Stryker
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerLymph Node MappingSentinel Lymph Node Biopsy
Start date
2019-01-04
Primary completion
2020-08-27
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.